[18F]AlF-NOTA-FAPI-04 PET/CT 对恶性与多种炎性肺病变的鉴别诊断价值:与[18F]FDG PET/CT 的比较
回顾性分析67例肿瘤患者的[18F]AlF-NOTA-FAPI-04 PET/CT,其中32例同时行[18F]FDG PET/CT,评估70个炎性及37个恶性肺病变。炎性病变两种示踪剂摄取均低于恶性病变(SUVmax、SUVmean、LBR均p<0.001),且FAPI-04摄取在不同类型炎性病变间存在差异,提示两种PET/CT均可能有助于鉴别恶性与炎性肺病变。
要点
- 炎性肺病变的[18F]AlF-NOTA-FAPI-04及[18F]FDG摄取均显著低于恶性病变(SUVmax、SUVmean、LBR均p<0.001)。
- [18F]AlF-NOTA-FAPI-04摄取在不同类型炎性病变间存在差异(SUVmax p=0.005),最高为感染性支气管扩张,最低为肺炎。
- 两种PET/CT均可用于鉴别恶性与多种炎性肺病变。
核心结论
- 炎性肺病变对[18F]AlF-NOTA-FAPI-04及[18F]FDG的摄取显著低于恶性病变,且不同类型炎性病变对FAPI-04摄取存在差异,两种PET/CT可能有助于鉴别恶性与多种炎性肺病变。
研究设计与样本
- 回顾性分析2020年12月至2022年1月67例肿瘤患者的[18F]AlF-NOTA-FAPI-04 PET/CT,其中32例同时行[18F]FDG PET/CT,计算SUVmax、SUVmean及LBR,并用ROC曲线分析半定量参数的预测能力。
关键影像表现/征象
- 炎性病变的[18F]AlF-NOTA-FAPI-04及[18F]FDG摄取均低于恶性病变,SUVmax、SUVmean、LBR差异均有统计学意义(均p<0.001)。
- [18F]AlF-NOTA-FAPI-04摄取在不同类型炎性病变间存在差异(SUVmax p=0.005;SUVmean p=0.008;LBR p<0.001),最高为感染性支气管扩张,其次为梗阻后肺炎,最低为肺炎。
- [18F]FDG摄取在梗阻后肺炎高于肺炎(SUVmax p=0.009;SUVmean p=0.016;LBR p=0.004)。
临床应用与阅片要点
- 阅片时需注意炎性肺病变对[18F]AlF-NOTA-FAPI-04及[18F]FDG均可有摄取,可能造成恶性假阳性。
- 不同类型炎性病变的[18F]AlF-NOTA-FAPI-04摄取存在差异,感染性支气管扩张及梗阻后肺炎摄取相对较高。
- 梗阻后肺炎的[18F]FDG摄取高于肺炎。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Uptake of the imaging tracers [18F]AlF-NOTA-FAPI-04 and [18F]FDG varies in some inflammatory lesions, which may result in false-positive findings for malignancy on PET/CT. Our aim was to compare the [18F]AlF-NOTA-FAPI-04 and [18F]FDG PET/CT imaging features of malignant and various inflammatory lung lesions and to analyze their value for differential diagnosis.
METHODS: We retrospectively analyzed [18F]AlF-NOTA-FAPI-04 PET/CT scans from 67 cancer patients taken between December 2020 and January 2022, as well as the scans of 32 patients who also underwent [18F]FDG PET/CT imaging. The maximum and mean standardized uptake values (SUVmax and SUVmean, respectively) and lesion-to-background ratio (LBR) were calculated. The predictive capabilities of semiquantitative PET/CT parameters were analyzed by receiver operating characteristic curve analysis.
RESULTS: A total of 70 inflammatory and 37 malignant lung lesions were evaluated by [18F]AlF‑NOTA‑FAPI‑04 PET/CT, and 33 inflammatory and 26 malignant lung lesions also were evaluated by [18F]FDG PET/CT. Inflammatory lesions exhibited lower [18F]AlF-NOTA-FAPI-04 and [18F]FDG uptake compared to malignant lesions, with statistically significant differences in SUVmax, SUVmean, and LBR (all p < 0.001). [18F]AlF-NOTA-FAPI-04 uptake also varied among different types of inflammatory lesions (SUVmax, p = 0.005; SUVmean, p = 0.008; LBR, p < 0.001), with the highest uptake observed in bronchiectasis with infection, followed by postobstructive pneumonia, and the lowest in pneumonia. [18F]FDG uptake was higher in postobstructive pneumonia than in pneumonia (SUVmax, p = 0.009; SUVmean, p = 0.016; LBR, p = 0.004).
CONCLUSION: [18F]AlF-NOTA-FAPI-04/[18F]FDG PET/CT showed significantly lower uptake in inflammatory lesions than malignancies as well as variation in different types of inflammatory lesions, and thus, may be valuable for distinguishing malignant and various inflammatory findings.
CLINICAL RELEVANCE STATEMENT: Our study confirmed that the uptake of [18F]AlF-NOTA-FAPI-04/[18F]FDG PET/CT in inflammatory and malignant lung lesions is different, which is beneficial to distinguish inflammatory and malignant lung lesions in clinic.
KEY POINTS: • Malignant and different inflammatory lung lesions showed varying degrees of uptake of [18F]AlF-NOTA-FAPI-04 and [18F]FDG. • Inflammatory lung lesions showed significantly less uptake than malignancies, and uptake varied among different types of inflammatory lesions. • Both types of PET/CT could differentiate malignant and various inflammatory lung findings.
引用
- Qiao K, Qin X, Fu S, et al. Value of [18F]AlF-NOTA-FAPI-04 PET/CT for differential diagnosis of malignant and various inflammatory lung lesions: comparison with [18F]FDG PET/CT. Eur Radiol. 2023. PMID: 37670186. doi:10.1007/s00330-023-10208-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。